...
首页> 外文期刊>Trends in molecular medicine >Targeting Obesity and Cachexia: Identification of the GFRAL Receptor–MIC-1/GDF15 Pathway
【24h】

Targeting Obesity and Cachexia: Identification of the GFRAL Receptor–MIC-1/GDF15 Pathway

机译:靶向肥胖症和恶病症:鉴定GFRAL受体-MIC-1 / GDF15途径

获取原文
获取原文并翻译 | 示例

摘要

Macrophage inhibitory cytokine-1/growth differentiation factor 15 (MIC-1/GDF15) is a divergent transforming growth factor (TGFβ) superfamily cytokine implicated in biological and disease processes including metabolism, cancer, and chronic inflammation, but whose receptor has remained elusive. Four laboratories have recently identified GFRAL, an orphan receptor of the glial-derived neurotrophic factor (GDNF) receptor α family, as the receptor for MIC-1/GDF15, signaling though the coreceptor Ret. These data identify a new systemic to central nervous system (CNS) circuit that regulates metabolism in response to stress and which could be targeted to treat both severe obesity and anorexia/cachexia syndrome.
机译:巨噬细胞抑制细胞因子-1 /生长分化因子15(MIC-1 / GDF15)是一种与生物和疾病方法有关的发散转化的生长因子(TGFβ)超家族细胞因子,包括代谢,癌症和慢性炎症,但受体仍然难以捉摸。 最近鉴定了四个实验室,胶质源性神经营养因子(GDNF)受体α系列的孤儿受体,作为MIC-1 / GDF15的受体,信号传导虽然是受体传递器RET。 这些数据鉴定了一种新的系统到中枢神经系统(CNS)电路,该电路调节代谢以应对压力,并且可以靶向治疗严重肥胖症和厌食症/恶病症综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号